| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |